RE:RE:RE:RE:RE:RE:Advisory Committee Outcomes RR:
No chance? Maybe one.Here is link to Oncologic drugs advisory committee and rosters throughout this year.
https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm426351.htm
They have rosters for July 9'15 and Jan7'15 meetings. About half attended both meetings .Here is how the committee is made up , we should just send Dr Morales and let him dunk the ball :
Committee Membership
The Committee shall consist of a core of 13 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of general oncology, pediatric oncology, hematologic oncology, immunologic oncology, biostatistics, and other related professions. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests.
GLTA Longs
13PD